USRE28536E - Animal husbandry - Google Patents
Animal husbandry Download PDFInfo
- Publication number
- USRE28536E USRE28536E US12122171A USRE28536E US RE28536 E USRE28536 E US RE28536E US 12122171 A US12122171 A US 12122171A US RE28536 E USRE28536 E US RE28536E
- Authority
- US
- United States
- Prior art keywords
- implant
- estrus
- medicament
- days
- cows
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 40
- 241000283690 Bos taurus Species 0.000 claims abstract description 54
- 230000012173 estrus Effects 0.000 claims abstract description 54
- 239000007943 implant Substances 0.000 claims abstract description 51
- 238000000034 method Methods 0.000 claims abstract description 31
- 239000003814 drug Substances 0.000 claims abstract description 29
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 241000283086 Equidae Species 0.000 claims abstract description 7
- 230000001360 synchronised effect Effects 0.000 claims abstract description 6
- 230000000144 pharmacologic effect Effects 0.000 claims abstract description 5
- 244000309465 heifer Species 0.000 claims description 22
- 239000008188 pellet Substances 0.000 claims description 10
- 239000010410 layer Substances 0.000 claims description 9
- 230000000903 blocking effect Effects 0.000 claims description 5
- 238000007920 subcutaneous administration Methods 0.000 claims description 5
- 241000282887 Suidae Species 0.000 claims description 3
- 239000012792 core layer Substances 0.000 claims description 3
- 239000003701 inert diluent Substances 0.000 claims 2
- 241001494479 Pecora Species 0.000 abstract description 7
- 238000001356 surgical procedure Methods 0.000 abstract description 4
- 238000009395 breeding Methods 0.000 description 17
- 230000001488 breeding effect Effects 0.000 description 17
- 230000009027 insemination Effects 0.000 description 16
- 244000144980 herd Species 0.000 description 12
- 235000015278 beef Nutrition 0.000 description 9
- 239000000203 mixture Substances 0.000 description 7
- 235000019687 Lamb Nutrition 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 244000309464 bull Species 0.000 description 6
- 235000013365 dairy product Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 241000283903 Ovis aries Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 description 2
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 2
- LVHOURKCKUYIGK-RGUJTQARSA-N Dimethisterone Chemical compound C1([C@@H](C)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@](C#CC)(O)[C@@]2(C)CC1 LVHOURKCKUYIGK-RGUJTQARSA-N 0.000 description 2
- 241000611421 Elia Species 0.000 description 2
- DOMWKUIIPQCAJU-LJHIYBGHSA-N Hydroxyprogesterone caproate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 DOMWKUIIPQCAJU-LJHIYBGHSA-N 0.000 description 2
- ICTXHFFSOAJUMG-SLHNCBLASA-N Norethynodrel Chemical compound C1CC(=O)CC2=C1[C@H]1CC[C@](C)([C@](CC3)(O)C#C)[C@@H]3[C@@H]1CC2 ICTXHFFSOAJUMG-SLHNCBLASA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- CHNXZKVNWQUJIB-CEGNMAFCSA-N ethisterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 CHNXZKVNWQUJIB-CEGNMAFCSA-N 0.000 description 2
- -1 ethylenedioxy Chemical group 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- FRQMUZJSZHZSGN-HBNHAYAOSA-N medroxyprogesterone Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](O)(C(C)=O)CC[C@H]21 FRQMUZJSZHZSGN-HBNHAYAOSA-N 0.000 description 2
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000777300 Congiopodidae Species 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241000920471 Lucilia caesar Species 0.000 description 1
- 241001272720 Medialuna californiensis Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 210000004198 anterior pituitary gland Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229960001616 chlormadinone acetate Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229950006690 dimethisterone Drugs 0.000 description 1
- 229960000445 ethisterone Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 230000001456 gonadotroph Effects 0.000 description 1
- 229960002899 hydroxyprogesterone Drugs 0.000 description 1
- 229950000801 hydroxyprogesterone caproate Drugs 0.000 description 1
- 229940060367 inert ingredients Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229960004616 medroxyprogesterone Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940053934 norethindrone Drugs 0.000 description 1
- 229960001858 norethynodrel Drugs 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009304 pastoral farming Methods 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000004739 secretory vesicle Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
Definitions
- the present invention involves an estrus block and enhancement method which predetermines when domestic animals such as cows, [sheep,] horses, etc., go into estrum.
- a medicament implant surgically inserted in the domestic animal slowly releases a medicament whose pharmacological action blocks occurrence of estrus, the total dosage available in the medicament implant being in excess of what will be absorbed over the residence period i.c., 14-18 days.
- Surgical removal of the implant after a predetermined period, i.c., from 141 8 days abruptly halts medication.
- onset of estrum for the entire group is synchronized and all may be artifically inseminated during the 2-7 days post removal period.
- the present invention relates to animal husbandry, and in particular to a technique for ensuring that a female domesticated animal goes into estrus at a desired predetermined time.
- the present invention provides, particularly, a technique for synchronization of estrus in a group of cows and heifers so that artificial insemination may be employed as the principal method of reproduction in the beef cattle industry.
- a cow observed in heat at the evening milking can be inseminated the following morning.
- Overall animal husbandry practices in the dairy industry including, for example, a relatively close confinement, supplementary feeding of concentrated high-energy feed stuffs, and heavy concentration of dairy herds in milk shed areas convenient to metropolitan centers have encouraged establishment of artificial insemination districts and regular routes therein.
- the principal object of the present invention is to provide an estrus blocking and enhancement technique.
- a further object of this invention is to provide a technique which allows predetermination of when a domestic animal goes into estrus.
- Still another object of the present invention is to provide a technique for synchronizing estrus for a large number of cows and heifers.
- the present invention involves a treatment sequence as follows:
- the animal may then be serviced.
- a large number, e.g., an entire herd, of breeding cows and heifers will be implanted at one time and the implants removed at one time. Then commencing on about the second post implant removal day and continuing until the seventh day the artificial inseminator will have available for insemination all of the cowsv and heifers in the herd. Insemination the 3rd, 4th and 5th day may suffice.
- the costs of artificial insemination thus spread among the large number of cows and heifers present in a breeding herd makes artificial insemination more economic than the heretofore practice of maintaining a number of breeding bulls for each large herd.
- manipulative techniques employed for practice of the present invention are not unknown to men who handle cattle herds and to veterinarians who treat cattle.
- they are passed through a squeezechute for a one by-one implantation according to facile implantation methods.
- the actual medicament (which generally speaking may betermed a hormone) employed in the implant depot to block occurrence of estrus may be selected from a large. number of materials. Many progestins exhibit this activity. Non-steroid materials such as stilbesterol and related stilbene compoundsalso act to block estrus. Indeed such medicaments or hormones are so widely known and so many of them are available in quantity that no particular medicament is singled out as preferred forpractice of the present invention.
- pregn-5-ene-20 Without being bound thereto it is theoried that the medicamentacts to block estrus by suppressing pituitary activity and cause the chromophilic series of anterior pituitary gland cells (beta variety) to shift into a high pre-secretory condition with an abundance of secretory granules therein. Then when the implant is removed and thereby medication is halted suddenly, a rebound phenomena occurs with hypersecretion of gonadotrophic hormones resulting in an active manifestaacetoxy, 6 methylment is absorbed from the implant depot. Further variation occurs in individual animal reaction to presence, subcutaneously, of the implant as a foreign body. To achieve synchronization a substantial total does (e.g. 200 mg.
- estrus block upon complete removal of the estrus block, there is opportunity for immediate rebound phenomena, producing an active well mainfested estrus in all the treated animals at what has become a predictable and uniform period of time, i.e. 27 days following removal of the estrus blocking implant.
- the normal variation from animal to animal alluded to above in: absorption rate, minimum dose, etc. results then in only a few days variation in timing of estrus, i.e., estrus now occurs between 27 days to post implant removal, and for cows and heifers 3-5 days may be more exact.
- Such a brief time period is self-evidently an improvement over the random pattern which normally would occur in a breeding herd.
- the cow is polyestrus with an average cycle of about 21 days, but individual animals may vary from 18-24days. Accordingly practice of this invention with its 14-18-day implant period and the 27 day waiting period roughly coincides with a normal cycle, serving in virtually every animal to delay estrus somewhat, which explains perphaps the rebound phenomena.
- the active ingredient should be formulated into a depot composition of limited solubility to provide for the desired slow absorption rate.
- theestrus blocking agents available e.g., the steriods, are themselves rela tively insoluable in aqueous media (i.e., lymph) facilitating thereby compounding and formulation.
- the depot may be a shaped pellet, e.g., in the form of a disc, oval, sphere, cube, etc., with the active ingredient concentrated in the outermost regions thereof, and only inert ingredients in the central or core regions.
- a relatively large inert core provides structural integrity for the pellet, avoiding disintegration thcreof during the implant residence period. Surgical removal of the encasement then takes with 'it all the residue of the pellet depot.
- a preferred depot for the implant is a three layer compressed powder disc shaped pellet wherein the active ingredient is present in appropriately diluted form only in the two outer layers of the disc; the large center (a) Formulation for upper and lower layers (each layer) Mg. Cholesterol 100 Active ingredient (Ii-ethylene dioxy l7-acetoxy, 6- methyl pregn-5ene-2(J-one) 100 Carbowax (4()()0)(a polyethylene glycol) 45 Magnesium stearate 5 Total 250 (b) Formulation for core layer Mg.
- the cows and heifers are confined for this 2-7-day period before estrus manifestation.
- the use of one or more vasectomized bulls equipped with colored chest markers can exactly indicate one by one when each cow and heifer comes into heat for subsequent prompt insemination.
- the close timing permits an alternative'scheme of inseminating all of the treated cows and heifers commencing on the second .post implant removal day and continuing for 35 more days.
- estrus blocking and enhancement technique of the present invention may be employed when suitable quality male animals are available and for other than the bovine species.
- the value of rams for W001 production reduce the importance of artificial insemination as a breeding technique.
- Nontheless, practice of the estrus block and enhancement technique of the present invention offers certain advantages in properly scheduling sheep breeding. The ewe shifts from an anestrus state to a polyestrun state at the end of summer. The lamb is dropped 5 months later. An economic advantage accrues to the sheep producer who is first with lambs or who is last with lambs.
- parenteral administration e.g., intramuscular, intraveneous, subcutaneous
- parenteral administration modes are distinguished by a lack of timing or synchronization. A planned for sudden cessation of medication in a group of animals is difficult to obtain.
- the pellet already described may be employed on horses.
- a mature sow requires approximately one-half the dosage of a cow and the already described composition in a smaller pellet size is applicable.
- sheep onequarter of the dosage described for the cow is adequate.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention involves an estrus block and enhancement method which predetermines when domestic animals such as cows, (sheep, ) horses, etc., go into estrum. A medicament implant surgically inserted in the domestic animal slowly releases a medicament whose pharmacological action blocks occurrence of estrus, the total dosage available in the medicament implant being in excess of what will be absorbed over the residence period i.e., 14-18 days. Surgical removal of the implant after a predetermined period, i.e., from 14-18 days abruptly halts medication. A rebound phenomena enhances estrus and onset of estrum occurs in from 2-7 days following removal of the implant. By treating a group of cows in this fashion, onset of estrum for the entire group is synchronized and all may be artifically inseminated during the 2-7 days post removal period.
Description
United States Patent 1191 Reed 1 Reissued Sept. 2, 1975 1 1 ANIMAL HUSBANDRY Jack Owen Reed, 81 Grand Ave., Englewood, NJ. 07605 [76] Inventor:
Reissue of:
[64] Patent No.: 3,499,445
Issued: Mar. 10, 1970 Appl. No.: 572,697 Filed: Aug. 16, 1966 [52] U.S. C1. 128/264; 424/19; 424/22; 128/270; 128/268 [51] Int. Cl. A61M 31/00 [58] Field of Search 128/271, 270, 264, 1 R, 128/260; 119/1; 424/19, 20, 31
[56] References Cited UNITED STATES PATENTS 2,541,447 2/1951 Turner ct a] 119/1 2,895,875 7/1959 Klcttc 424/31 2,943,979 7/1960 Elias 128/270 X 2,987,445 6/1961 Levesque 424/22 3,262,450 7/1966 Elias 128/270 3,279,996 10/1966 Long et a1 424/19 FORElGN PATENTS OR APPLICATIONS 562,095 8/1958 Canada 424/22 722,629 6/1955 United Kingdom 424/19 OTHER PUBLICATIONS Nature 206, p. 394l, Apr. 3 1965. Use of Progestagen-Impregnated Sponges Inserted lntravaginally or subcutaneously for the Control of the Oestrous Cycle in Sheep.
Primary Examiner-Aldrich F. Medbery Attorney, Agent, or Firm-Fidelman, Wolffe & Leitner [5 7 ABSTRACT The present invention involves an estrus block and enhancement method which predetermines when domestic animals such as cows, [sheep,] horses, etc., go into estrum. A medicament implant surgically inserted in the domestic animal slowly releases a medicament whose pharmacological action blocks occurrence of estrus, the total dosage available in the medicament implant being in excess of what will be absorbed over the residence period i.c., 14-18 days. Surgical removal of the implant after a predetermined period, i.c., from 141 8 days abruptly halts medication. A rebound phenomena enhances estrus and onset of estrum occurs in from 27 days following removal of the implant. By treating a group of cows in this fashion, onset of estrum for the entire group is synchronized and all may be artifically inseminated during the 2-7 days post removal period.
7 Claims, N0 Drawings ANIMAL HUSBANDRY Matter enclosed in heavy brackets I: 1 appears in the original patent but forms no part of this reissue specification; matter printed in italics indicates the additions made by reissue.
The present invention relates to animal husbandry, and in particular to a technique for ensuring that a female domesticated animal goes into estrus at a desired predetermined time.
Breeding of domesticated animals according to their normal estrus cycles involves practical disadvantages which have long been recognized in animal husbandry. For example, the characteristic of a spring lamb crop depresses the price of fresh lamb at a certain time of the year, and makes fresh lamb unavailable at other times. A shift in the breeding cycle of the ewe to provide for either an early lamb or a late lamb would be desirable. Similarly, foaling of race horses between January l and is highly desirable but not always at tained. In some respects the problems in breeding beef cattle are particularly severe.
The large number of cattle (bovine species) and their economic value makes imperative breeding cows and heifers with the least possible number of highest quality bulls. The present invention provides, particularly, a technique for synchronization of estrus in a group of cows and heifers so that artificial insemination may be employed as the principal method of reproduction in the beef cattle industry.
Use of artificial insemination in breeding of cattle is now a standard technique but in large scale practice has been limited principally to dairy and other closely observed cows. Generally speaking, artificial insemination must be timed exactly to the period of estrus in the cow (about 14 hours) else it fails. As a practical matter this means that the animal must be under daily observa tion. Milking cows are observed at least twice a day for milking purposes, making it possible to observe exactly when each cow in the herd is in estrum. The services of an inseminator can be called for as required. In addition the cows of a dairy herd are easily confined and any one cow may be made available for insemination without difficulty. A cow observed in heat during the morning milking can be inseminated that afternoon. A cow observed in heat at the evening milking can be inseminated the following morning. Overall animal husbandry practices in the dairy industry including, for example, a relatively close confinement, supplementary feeding of concentrated high-energy feed stuffs, and heavy concentration of dairy herds in milk shed areas convenient to metropolitan centers have encouraged establishment of artificial insemination districts and regular routes therein.
The beef cattle industry however has, to a great extent, been unable to employ artificial insemination as a breeding technique, and in consequence, carries the economic load ofan excessively large number of breeding bulls. The circumstances which make artificial insemination of dairy cattle feasible on a large scale, are absent in the beef cattle industry. Beef-cattle breeding cows and heifers are not normally confined. The many beef breeding herds are widely separated, and, routinely, are moved about on great tracts of grazing land: The cattle forage at will over the land, utilizing native grasses as their principal feed source. Only during period of scarce grass supply are they given limited supplemental moderate-energy feeds. The individual cows and heifers are not observed closely and the signs of estrus often pass unnoticed. Providing for an almost daily service by an inseminator in the vast thinly populated areas where beef cattle roam would involve a prohibitive expense.
However, if a substantial number of cows and heifers can be brought at one time into a fertile reproductive cycle, with estrus occurring more or less simultaneously, then artificial insemination techniques may be employed on beef cattle economically. Teams of inseminators could be arranged for in advance and large quantities of viable semen from frozen storage supplies made available to any preselected location.
The principal object of the present invention is to provide an estrus blocking and enhancement technique.
A further object of this invention is to provide a technique which allows predetermination of when a domestic animal goes into estrus.
Still another object of the present invention is to provide a technique for synchronizing estrus for a large number of cows and heifers.
Other objects and the advantages of the present invention will become more apparent from the detailed description thereof which follows.
Briefly stated the present invention involves a treatment sequence as follows:
(i) Surgically implanting a depot pellet whose pharmacologic action blocks occurrence of estrus during a period the female domestic animal would normally undergo estrus.
(ii) Permitting the implant to remain for about 14-18 days, during which period the medicament therein is released continuously and acts to block estrus.
(iii) Surgically removing the implant at the expiration of the 14- l 8 day period, thereby abruptly halting medication and by rebound phenomena enhance the estrus which occurs from 2-7 days following removal of the implant.
The animal may then be serviced.
According to practice of a preferred mode of the invention a large number, e.g., an entire herd, of breeding cows and heifers will be implanted at one time and the implants removed at one time. Then commencing on about the second post implant removal day and continuing until the seventh day the artificial inseminator will have available for insemination all of the cowsv and heifers in the herd. Insemination the 3rd, 4th and 5th day may suffice. The costs of artificial insemination thus spread among the large number of cows and heifers present in a breeding herd makes artificial insemination more economic than the heretofore practice of maintaining a number of breeding bulls for each large herd.
Aside from eliminating the out-of-pocket and other expenses of maintaining a bull herd solely for breeding purposes, synchronizing estrus by practice of the present invention and artificial insemination with semen from high quality bulls upgrades the quality of the calves.
Individually the manipulative techniques employed for practice of the present invention are not unknown to men who handle cattle herds and to veterinarians who treat cattle. Thus, after the first preliminary step of simply to assemble or roundup the animals in customary fashion, they are passed through a squeezechute for a one by-one implantation according to facile implantation methods. Apreferred-technique of implantation, using sanitary surgicalprocedures, in the mid-cervical area,. one to two inches ventral to the transverse process of the cervical vertebrae, is to cut a horizontal straight line opening through the skin only, approximately 1.5 inches in length. Introduce a pair of tissue separating forceps ventrally between the skin and the underlying musculature for approximately 1.5 inches, opening the forceps to form a subcutaneous pouch to receive the implant. The forceps are removed and the implant is introduced into the subcutaneous pouch. One or two mattress sutures then close the wound. If implantation is done during the fly season the wound should be protected against blow-fly infestation. The animal is then released from the squeeze-chute and is allowed to return to pasture. I
'.F()I' removal of the implant,after 14-18 days have elapsed the herd is again rounded up and each animal passed through a squeeze-chute. A second incision is made through the skin, immediately below the palpible implant. This incision should be of a half moon shape, apex ventral. The encasement around the residue of the implant pellet is then grasped with a surgical hook or a pair of tissue forceps and withdrawn from its subcutaneous depot site through the wound opening. Again the wound is closedwith one or two mattress sutures providing for drainage at the appex, should irritation develop; a
The actual medicament (which generally speaking may betermed a hormone) employed in the implant depot to block occurrence of estrus may be selected from a large. number of materials. Many progestins exhibit this activity. Non-steroid materials such as stilbesterol and related stilbene compoundsalso act to block estrus. Indeed such medicaments or hormones are so widely known and so many of them are available in quantity that no particular medicament is singled out as preferred forpractice of the present invention.
Following is a partial list of steroids which have .been found suitable for practice of the present invention:
(1) Chlormadinone acetate (2) Dimethisterone (3) Ethisterone (4) .Hydroxyprogesterone (5) Hydroxyprogesterone caproate (6) Medroxyprogesterone (7) Norethindrone (8) Norethynodrel (9) Progesterone (10) 3 ethylenedioxy, 17
pregn-5-ene-20 Without being bound thereto it is theoried that the medicamentacts to block estrus by suppressing pituitary activity and cause the chromophilic series of anterior pituitary gland cells (beta variety) to shift into a high pre-secretory condition with an abundance of secretory granules therein. Then whenthe implant is removed and thereby medication is halted suddenly, a rebound phenomena occurs with hypersecretion of gonadotrophic hormones resulting in an active manifestaacetoxy, 6 methylment is absorbed from the implant depot. Further variation occurs in individual animal reaction to presence, subcutaneously, of the implant as a foreign body. To achieve synchronization a substantial total does (e.g. 200 mg. steroid) must therefore be made available to insure absorption of at least the minimumdose needed to attain the desired estrus blocking action. Fortunately, absorption from the implant of substantially larger quantities of active ingredient than are needed has not proven harmful to cows and heifers (orto otherdomestic animals). Presence of a substantial excess of active ingredient over and above the maximum quantity that might be absorbed by the animal in the 14-18-dayimplant residence period is important to estrus synchronization. The desired synchronization of estrus in a large number of cows and heifers in attained by essentially simultaneous cessation of medication to each animal. To repeat, the depot life is intended to be longer than the planned for 14-18 days of implant residence.
Then upon complete removal of the estrus block, there is opportunity for immediate rebound phenomena, producing an active well mainfested estrus in all the treated animals at what has become a predictable and uniform period of time, i.e. 27 days following removal of the estrus blocking implant. The normal variation from animal to animal alluded to above in: absorption rate, minimum dose, etc., results then in only a few days variation in timing of estrus, i.e., estrus now occurs between 27 days to post implant removal, and for cows and heifers 3-5 days may be more exact. Such a brief time period is self-evidently an improvement over the random pattern which normally would occur in a breeding herd. The cow is polyestrus with an average cycle of about 21 days, but individual animals may vary from 18-24days. Accordingly practice of this invention with its 14-18-day implant period and the 27 day waiting period roughly coincides with a normal cycle, serving in virtually every animal to delay estrus somewhat, which explains perphaps the rebound phenomena. I
Allusion has already been made to need for extended life in the implant. in consequence the active ingredient should be formulated into a depot composition of limited solubility to provide for the desired slow absorption rate. Advantageously many of theestrus blocking agents available, e.g., the steriods, are themselves rela tively insoluable in aqueous media (i.e., lymph) facilitating thereby compounding and formulation. An additional factor which must be considered is that need for ultimate removal of the implant dictates, first some sort of porous or foraminous encasement for the implant depot which can be grasped (by forceps or the like) for removal, and seconda depot which will not disintegrate tion of estrus within 27 days, often in cows and Variations exist also in the rapidity with which medica-- to leave behind unabsorbed particles of active medicament. Advantageously, the depot may be a shaped pellet, e.g., in the form of a disc, oval, sphere, cube, etc., with the active ingredient concentrated in the outermost regions thereof, and only inert ingredients in the central or core regions. A relatively large inert core provides structural integrity for the pellet, avoiding disintegration thcreof during the implant residence period. Surgical removal of the encasement then takes with 'it all the residue of the pellet depot.
A preferred depot for the implant is a three layer compressed powder disc shaped pellet wherein the active ingredient is present in appropriately diluted form only in the two outer layers of the disc; the large center (a) Formulation for upper and lower layers (each layer) Mg. Cholesterol 100 Active ingredient (Ii-ethylene dioxy l7-acetoxy, 6- methyl pregn-5ene-2(J-one) 100 Carbowax (4()()0)(a polyethylene glycol) 45 Magnesium stearate 5 Total 250 (b) Formulation for core layer Mg. Cholesterol 2000 Carbowax (400(1) 450 Magnesium stearate 50 Total 2500 The above formulations are compounded then compressed in separate layers with the active formulations as the outside layers using commercially available tableting equipment. When the 3-layer disc shaped tablets are employed as implants (using a polyethylene foraminous encasement) on beef cows and heifers estrus occurs in the entire group in from a 2-7-day post implant period.
Desirably, the cows and heifers are confined for this 2-7-day period before estrus manifestation. The use of one or more vasectomized bulls equipped with colored chest markers, can exactly indicate one by one when each cow and heifer comes into heat for subsequent prompt insemination. However, the close timing permits an alternative'scheme of inseminating all of the treated cows and heifers commencing on the second .post implant removal day and continuing for 35 more days.
While the present invention has been described principally in terms of beef cattle and artificial insemination it should be appreciated that the estrus blocking and enhancement technique of the present invention may be employed when suitable quality male animals are available and for other than the bovine species. For sheep breeding, for example, the value of rams for W001 production reduce the importance of artificial insemination as a breeding technique. Nontheless, practice of the estrus block and enhancement technique of the present invention offers certain advantages in properly scheduling sheep breeding. The ewe shifts from an anestrus state to a polyestrun state at the end of summer. The lamb is dropped 5 months later. An economic advantage accrues to the sheep producer who is first with lambs or who is last with lambs. Employment, therefore, of the estrus block and enhancement technique of the present invention in multiparous ewes about September l assures that this group of ewes gestatc on their first estrus cycle and drop the earliest lambs for later early marketing purposes. Conversely, employ- Qmentof th'etechnique inlate November on virgin ewes results in delayed conception for this group and avery late-spring-lamp ;crop. As a' side effect the-number" of lambs pr'oduced e atpeak production period (about March) becomes reduced. Practice of therpresen-t invention has'been described Withojut allusion to" alternative" t'echnic[uesfor estrus block and-enhancement? Prior are efforts along such lines through oral medication are'known (certainly in humans). However, oral techniques are-not particularly applicable to r'uininants-lik'e 'sliep'andcows. Individual variations in appetite and the multiple stomachs, of ruminan'ts combineto reduce to a virtuallince'rtainty the affect of o'i'ally ingested 'estfusblocking medications; This unpredictability of effect is worse when the animals are fed en masse. A crowding factor (sometimes known as pecking order in chickens) causes the more aggressive animals to monopolize feed supplies. Timid animals might not even obtain sufficient feed to be properly dosed.
Other types of parenteral administration e.g., intramuscular, intraveneous, subcutaneous, typically are in fluid paste or other forms that suffer from the disadvantages of being in a non-removable form which must remain active until its pharmocological action is exhausted. These administration modes are distinguished by a lack of timing or synchronization. A planned for sudden cessation of medication in a group of animals is difficult to obtain.
Even in non-ruminant animals such as horses and pigs, parenteral administration of a removable implant according to practice of present invention may be more advantageous than oral administration. Horses are a relatively small but important area of use because of the well known desirability of foaling between January lst and January l5th. By practice of the present invention an early full estrus period may be produced in lieu of a first quiescent early estrus (as is normal in the mare) which may pass unnoticed by the stallion, thereby attaining a January l-l 5 foaling date instead of one a cycle (twenty-two days) later when full estrus manifestation would normally occur.
The pellet already described may be employed on horses. A mature sow requires approximately one-half the dosage of a cow and the already described composition in a smaller pellet size is applicable. For sheep onequarter of the dosage described for the cow is adequate.
What is claimed is:
1. An estrus block and enhancement technique which comprises:
(i) surgically I subcutaneously inserting into a female domestic animal selected from the group consisting of cattle, horses and pigs an implant of a medicament whose pharmacologic action blocks occurrence of estrus,
(ii) permitting the implant to remain in the animal and continuously release medicament for about 14-18 days, said implant being adapted to release medicament continuously for at least l8 days, and
(iii) surgically removing said implant at the expiration of said l418-day waiting period, thereby halting medication, whereby a rebound phenomenon enhances estrus and onset of estrum occurs in from 2-7 days following removal of said implant.
2. The method of claim 1 wherein multiple numbers of female animals are implanted at one time and im- 7 plants are removed at one time and synchronized estrus in the so treated group is attained. 4
3. The method of claim 1 wherein the female anima is artificially inseminated daily during said 2-7-day period.
4. The method of claim 1 wherein a plurality of cows and heifers are implanted at one time and the implants removed at one time, whereby estrus'of the group is synchronized to within a Z-J-day period.
The method of claim'4 wherein said cows and heifers are artificially inseminated daily during said 2-7- day period.
6. The method of claim 4 wherein said cows and heifers are artificially inseminated daily for the 3rd, 4th,
Claims (7)
1. An estrus block and enhancement technique which comprises: (i) (surgically) subcutaneously inserting into a female domestic animal selected from the group consisting of cattle, horses and pigs an implant of a medicament whose pharmacologic action blocks occurrence of estrus, (ii) permitting the implant to remain in the animal and continuously release medicament for about 14-18 days, said implant being adapted to release medicament continuously for at least 18 days, and (iii) surgically removing said implant at the expiration of said 14-18-day waiting period, thereby halting medication, whereby a rebound phenomenon enhances estrus and onset of estrum occurs in from 2-7 days following removal of said implant.
2. The method of claim 1 wherein multiple numbers of female animals are implanted at one time and implants are removed at one time and synchronized estrus in the so treated group is attained.
3. The method of claim 1 wherein the female animal is artificially inseminated daily during said 2-7-day period.
4. The method of claim 1 wherein a plurality of cows and heifers are implanted at one time and the implants removed at one time, whereby estrus of the group is synchronized to within a 2-7-day period.
5. The method of claim 4 wherein said cows and heifers are artificially inseminated daily during said 2-7-day period.
6. The method of claim 4 wherein said cows and heifers are artificially inseminated daily for the 3rd, 4th, 5th post implant removal days.
8. A depot adapted for subcutaneous implant purposes comprising an estrus blocking medicament compounded with inert diluent and formulated into a multilayer pellet, with said medicament being present only in the outermost layer portions of said pellet and at least one core layer containing only a non-dissolving inert diluent, said core layer being substantially larger than the medicament containing outermost layer portions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12122171 USRE28536E (en) | 1966-08-16 | 1971-03-04 | Animal husbandry |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57269766A | 1966-08-16 | 1966-08-16 | |
US12122171 USRE28536E (en) | 1966-08-16 | 1971-03-04 | Animal husbandry |
Publications (1)
Publication Number | Publication Date |
---|---|
USRE28536E true USRE28536E (en) | 1975-09-02 |
Family
ID=26819233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12122171 Expired USRE28536E (en) | 1966-08-16 | 1971-03-04 | Animal husbandry |
Country Status (1)
Country | Link |
---|---|
US (1) | USRE28536E (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4191741A (en) | 1978-09-22 | 1980-03-04 | Eli Lilly And Company | Removable drug implant |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2541447A (en) * | 1945-04-09 | 1951-02-13 | American Dairies Inc | Composition for altering physiological processes of livestock and poultry and process of using same |
GB722629A (en) * | 1952-07-22 | 1955-01-26 | Edward Charles Edmund Hemsted | Improvements in and relating to tampons, wads or the like, and materials therefor |
CA562095A (en) * | 1958-08-19 | Burroughs Wise | Method of treating growing beef cattle and sheep | |
US2895875A (en) * | 1950-10-20 | 1959-07-21 | Erich M H Radde | Subcutaneous hormone pellets |
US2943979A (en) * | 1959-06-23 | 1960-07-05 | Nathaniel M Elias | Concentrated foam-producing spermicides |
US2987445A (en) * | 1958-10-10 | 1961-06-06 | Rohm & Haas | Drug composition |
US3262450A (en) * | 1962-04-02 | 1966-07-26 | Nathaniel M Elias | Vaginal applicator |
US3279996A (en) * | 1962-08-28 | 1966-10-18 | Jr David M Long | Polysiloxane carrier for controlled release of drugs and other agents |
-
1971
- 1971-03-04 US US12122171 patent/USRE28536E/en not_active Expired
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA562095A (en) * | 1958-08-19 | Burroughs Wise | Method of treating growing beef cattle and sheep | |
US2541447A (en) * | 1945-04-09 | 1951-02-13 | American Dairies Inc | Composition for altering physiological processes of livestock and poultry and process of using same |
US2895875A (en) * | 1950-10-20 | 1959-07-21 | Erich M H Radde | Subcutaneous hormone pellets |
GB722629A (en) * | 1952-07-22 | 1955-01-26 | Edward Charles Edmund Hemsted | Improvements in and relating to tampons, wads or the like, and materials therefor |
US2987445A (en) * | 1958-10-10 | 1961-06-06 | Rohm & Haas | Drug composition |
US2943979A (en) * | 1959-06-23 | 1960-07-05 | Nathaniel M Elias | Concentrated foam-producing spermicides |
US3262450A (en) * | 1962-04-02 | 1966-07-26 | Nathaniel M Elias | Vaginal applicator |
US3279996A (en) * | 1962-08-28 | 1966-10-18 | Jr David M Long | Polysiloxane carrier for controlled release of drugs and other agents |
Non-Patent Citations (1)
Title |
---|
"Nature" 206, p. 39-41, Apr. 3, 1965. Use of Progestagen-Impregnated Sponges Inserted Intravaginally or Subcutaneously for the Control of the Oestrous Cycle in Sheep * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4191741A (en) | 1978-09-22 | 1980-03-04 | Eli Lilly And Company | Removable drug implant |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3499445A (en) | Animal husbandry | |
Bretzlaff et al. | Clinical use of norgestomet ear implants or intravaginal pessaries for synchronization of estrus in anestrous dairy goats | |
Fesseha et al. | Estrus detection, Estrus synchronization in cattle and it’s economic importance | |
Loerch et al. | Use of trainer animals to improve performance and health of newly arrived feedlot calves | |
Hulet et al. | Some factors affecting response of anestrous ewes to hormone treatment | |
USRE28536E (en) | Animal husbandry | |
Roughton | Effects of oral melengestrol acetate on reproduction in captive white-tailed deer | |
Chaudhari et al. | Synchronization of Estrus: A reproductive management tool in veterinary practice | |
Smith et al. | Implant sequence effects in intact male Holstein veal calves: live and slaughter traits | |
Jainudeen et al. | Induction of parturition in crossbred sows with cloprostenol, an analogue of prostaglandin F2α | |
Greyling et al. | Effect of controlled breeding on performance of beef cattle in Central Bushveld bioregion | |
Keefe et al. | Evaluation of melengestrol acetate and equine chorionic gonadotropin for out-of-season breeding in sheep on Prince Edward Island. | |
US4472394A (en) | Method for increasing weight in domestic animals | |
US4870066A (en) | Method and composition for safely delaying parturition and synchronizing farrowing in swine | |
Suastiningsih et al. | Evaluation of one shot and two shot prostaglandin injection on estrus response in Bali cattle. | |
Voss et al. | Controlling estrus in dairy cows—A comparative field study | |
US5238928A (en) | Methods and materials for obtaining phenotypic females despite androgen administration | |
Putnam | Parturition: a mechanism review: induction, intervention, and calf viability | |
White et al. | Influence of mating on duration of estrus in captive white-tailed deer | |
Thomas | 2021 protocols for natural service bull breeding | |
McCartney et al. | The effectiveness of 48-hour calf removal, Syncro-Mate-B or prostaglandin treatments in advancing the breeding season of beef cows | |
Balan-May et al. | Short-term protocols for the estrus synchronization in hair sheep in Campeche, Mexico | |
Sharma | Effect of hormonal treatment on induction of milk in crossbred cattle | |
Smith | Techniques and hazards of oestrus synchronization | |
Boonbrahm et al. | The influence of calf rearing methods and milking methods on performance traits of crossbred dairy cattle in Thailand–2. Reproductive performance and cow body weight |